Profhilo is the first injectable of its kind, used to treat skin laxity and give patients who want to avoid synthetics another option to address issues such as skin laxity and poor hydration.
Using Nahyco technology, Profhilo uses thermal cross-linking to stimulate four different types of collagen and elastin by the slow release of hyaluronic acid (HA), which is key to skin rejuvenation and younger-looking skin.
This stimulation sees a significant tissue improvement, both in tightening and in hydration, because not only does it boost and hydrate the skin, but it also remodels the ageing and sagging tissue – as well as reducing any risk of side effects due to its lack of additives, unlike traditional dermal fillers.
That is what makes this injectable unique – rather than using synthetic cross-linking chemicals, known as BDDEs, which are regularly used in dermal fillers to reduce the breakdown of HA, it uses a higher concentration of HA for equally effective skin quality results.
While it doesn’t necessarily give volume lift or volume replacement, as with dermal fillers, it does create volume in tissue where it is needed most due to its high spreadability, which means it can also be used in those normally hard-to-reach areas – such as the as the hands, neck and arms.